Laboratory of Molecular Neuropharmacology, Biophysics and Bioinformatics

  • Postal addressShow on map

    Edifici M, Campus UAB

    08193 Bellaterra (Cerdanyola del Vallès)


Organisation profile

Organisation profile

The group aims to significantly contribute to the understanding of the molecular mechanisms
involved in neurologic and psychiatric diseases, in particular, chronic pain, Alzheimer's and
Lesch-Nyhan diseases and schizophrenia. An integrative multidisciplinary approach is applied
including in silico, in vitro, animal models, and human research. In this context, G proteincoupled receptors, in particular, the mu-, delta-, and kappa-opioid receptors, cannabinoid CB1
and CB2 and dopamine D2 receptor, as well as ion channels, such as TRPV, are used as
therapeutic targets. In addition, colloidal systems that incorporate complexed metals which
allow the release of CO for pain modulation are included. The investigations also incorporate
brain delivery of Alzheimer’s antiamyloidogenic agents in the form of encapsulated dendrimers
using nano-vehicles that can be extended to other pathologies. Functional studies are
complemented by synchrotron-based imaging techniques on human brain samples.

UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being


Dive into the research topics where Laboratory of Molecular Neuropharmacology, Biophysics and Bioinformatics is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or